Alyesa Organa
The Hidden Architect
SPECIAL FEATURES
XFT-11 "Clearline" is a single-use IV filtration patch developed by XeroCorp Technologies for frontline soldiers, covert operatives, and high-risk medical deployments. When applied to a major vein area (typically forearm or neck), the patch activates a biosensor suite that immediately scans the user's bloodstream for chemical anomalies. If toxins, stimulants, or biological agents are detected, the patch activates its microfiltration membrane and begins purging contaminants while stabilizing core vitals.
Clearline units are commonly pre-programmed with neutralization routines for known combat drugs or battlefield toxins. More advanced users customize their patches with personal counteragent profiles uploaded through external medical systems. Once activated, the patch can complete a full detox cycle in under three minutes.
The system is highly effective for standard poisons, performance enhancers, or overdose situations, but less reliable against synthetic or mutagenic compounds engineered to bypass biological filtration. While openly available on the market, many high-tier Clearline variants remain proprietary to XeroCorp's special operations arm, particularly those with embedded compound-response AI or encrypted chemical libraries.
- Transdermal patch with internal toxin filters and biosensors
- Detects and neutralizes organic poisons, narcotics, and combat drugs
- Programmable chemical neutralization profiles
- Auto-injection system for stabilizers or preloaded counteragents
- Low-profile and adhesive for quick application
- Provides immediate bloodstream detoxification in the field
- Programmable to counteract specific toxins or drugs in advance
- Lightweight and easily carried or worn for constant readiness
- Single-use; must be replaced or recharged after activation
- Ineffective against synthetic nanotoxins or exotic biochemical agents
- May trigger withdrawal shock in users addicted to filtered compounds
XFT-11 "Clearline" is a single-use IV filtration patch developed by XeroCorp Technologies for frontline soldiers, covert operatives, and high-risk medical deployments. When applied to a major vein area (typically forearm or neck), the patch activates a biosensor suite that immediately scans the user's bloodstream for chemical anomalies. If toxins, stimulants, or biological agents are detected, the patch activates its microfiltration membrane and begins purging contaminants while stabilizing core vitals.
Clearline units are commonly pre-programmed with neutralization routines for known combat drugs or battlefield toxins. More advanced users customize their patches with personal counteragent profiles uploaded through external medical systems. Once activated, the patch can complete a full detox cycle in under three minutes.
The system is highly effective for standard poisons, performance enhancers, or overdose situations, but less reliable against synthetic or mutagenic compounds engineered to bypass biological filtration. While openly available on the market, many high-tier Clearline variants remain proprietary to XeroCorp's special operations arm, particularly those with embedded compound-response AI or encrypted chemical libraries.
Out Of Character Info
Intent:
To provide a compact, programmable IV patch capable of rapidly filtering toxins, narcotics, and biochem contaminants from a user’s bloodstream
Permissions:
N/A
Technical Information
Affiliation:
XeroMed, XeroCorp Technologies, Open-Market Users, Independent Medical Providers, Private Security Forces
Modular:
No
Material:
To provide a compact, programmable IV patch capable of rapidly filtering toxins, narcotics, and biochem contaminants from a user’s bloodstream